Jihui Hao, M.D., Ph.D.

M.D., Ph.D. Tianjin Medical University

Major Previous Appointments
2010-      Professor, Vice President, TMUCIH

2009-2010  Professor, Department of Pancreatic Tumor, TMUCIH

2004-2009  Associate Professor, Department of Pancreatic Tumor, TMUCIH

2002-2004  Post doctoral fellowship, Department of Oncology, Queen Mary College, University of London, UK. 

Fields of Interests
pancreatic cancer surgical treatment and basic research

Major publications

1: Liu J, Jiang W, Zhao K, Wang H, Zhou T, Bai W, Wang X, Zhao T, Huang C, Gao S,Qin T, Yu W, Yang B, Li X, Fu D, Tan W, Yang S, Ren H, Hao J. Tumoral EHFpredicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma. J Exp Med. 2019 Mar 4;216(3):656-673.


2: Huang C, Li Y, Li Z, Xu Y, Li N, Ge Y, Dong J, Chang A, Zhao T, Wang X, Wang H, Yang S, Xie K, Hao J, Ren H. LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation. Clin Cancer Res. 2019 Jan 24.


3: Huang C, Li Z, Li N, Li Y, Chang A, Zhao T, Wang X, Wang H, Gao S, Yang S, Hao J, Ren H. Interleukin 35 Expression Correlates With Microvessel Density

in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and  Angiogenesis of Xenograft Tumors in Mice. Gastroenterology. 2018



4: Huang C, Li N, Li Z, Chang A, Chen Y, Zhao T, Li Y, Wang X, Zhang W, Wang Z, Luo L, Shi J, Yang S, Ren H, Hao J. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression. Nat Commun. 2017 Jan 19;8:14035.


5: Zhao T, Jiang W, Wang X, Wang H, Zheng C, Li Y, Sun Y, Huang C, Han ZB, Yang S, Jia Z, Xie K, Ren H, Hao J. ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin. Cancer Res. 2017 Feb 15;77(4):874-885.